Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nerve growth factor delivery systems

M F Haller1, W M Saltzman

  • 1School of Chemical Engineering, Cornell University, Ithaca, NY 14853, USA.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|September 19, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors.

Molecular cancer therapeutics·2024
Same author

Monobody adapter for functional antibody display on nanoparticles for adaptable targeted delivery applications.

Nature communications·2022
Same author

Nerve growth factor delivery and cell aggregation enhance choline acetyltransferase activity after neural transplantation.

Tissue engineering·2009
Same author

Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2008
Same author

Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.

Biomaterials·2008
Same author

Nonviral gene delivery: thinking of silica.

Gene therapy·2007
Same journal

Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

A one-step surface engineering strategy based on PEG-EGCG to improve systemic delivery and survival of transplanted mesenchymal stromal cells.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Selective silencing of placental anti-angiogenic factors in invasive trophoblasts via membrane-fusion divalent siRNA delivery for preeclampsia therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Unified inactivation-mineralization: An engineered bacterial platform for synergistic radio-immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Loss of internal structural order induced by freezing and Lyophilization correlates with reduced in vitro activity of mRNA lipid nanoparticles.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacy.

Journal of controlled release : official journal of the Controlled Release Society·2026
See all related articles

Growth factors promote tissue repair and neural regeneration. Controlled-release systems offer sustained delivery for treating neurodegenerative diseases like Alzheimer's and Parkinson's by supporting cell survival.

Area of Science:

  • Biomedical Engineering
  • Neuroscience
  • Regenerative Medicine

Background:

  • Growth factors are key regulators of tissue regeneration, differentiation, wound healing, and neural repair.
  • Neurodegenerative diseases (e.g., Alzheimer's, Parkinson's) involve progressive loss of neuronal cells.
  • Current treatments often focus on symptom management rather than addressing underlying neuronal degeneration.

Purpose of the Study:

  • To explore the potential of growth factor administration as a therapeutic strategy for neurodegenerative diseases.
  • To investigate the role of controlled-release polymer delivery systems in sustained growth factor delivery.
  • To assess the feasibility of preventing neuronal degeneration and stimulating neuronal regeneration.

Main Methods:

  • Review of existing literature on growth factors and their role in neural repair.

Related Experiment Videos

  • Analysis of controlled-release polymer technologies for drug delivery.
  • Examination of preclinical and clinical data on growth factor applications in neurodegenerative models.

    • Main Results:

    • Growth factors demonstrate significant potential in promoting neuronal survival and regeneration.
    • Controlled-release systems can provide sustained delivery of growth factors, overcoming limitations of short half-lives.
    • This approach may enable long-term support for endogenous or transplanted cells in neurodegenerative conditions.

    Conclusions:

    • Sustained delivery of growth factors via controlled-release systems holds promise for treating neurodegenerative diseases.
    • This technology could offer a novel strategy for preventing neuronal loss and promoting neural repair.
    • Further research and development are warranted to translate this potential into clinical applications.